home / stock / avcn:cc / avcn:cc news

AVCN:CC News and Press, Avicanna Inc. From 04/18/24

Stock Information
Company Name: Avicanna Inc.
Stock Symbol: AVCN:CC
Market: TSXC
Website: avicanna.com
Menu
AVCN:CC AVCN:CC Quote AVCN:CC Short AVCN:CC News AVCN:CC Articles AVCN:CC Message Board
Get AVCN:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
AVCN:CC - Avicanna Announces Closing of Non-brokered Private Placement

TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based pro...
AVCN:CC - Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study

TORONTO, April 10, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based pro...

AVCN:CC - Avicanna Reports Full Year 2023 Audited Financial Results 

$16.8M in Revenue, representing an increase of 314% from 2022 $6.7M Consolidated gross Profit, representing an increase of 500% from 2022 TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ) (TSX: AVCN) (OTCQX: AVCNF) ...

AVCN:CC - Avicanna Announces the Canadian Launch of 10% CBD (THC Free) Proprietary Formulation

The 10% CBD (THC free) proprietary oral formulation branded as RHO Phyto Micro Drop 100 in Canada RHO Phyto Micro Drop 100 is available exclusively at MyMedi.ca. TORONTO, March 27, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company )...
AVCN:CC - Avicanna To Hold Full Year 2023 Earnings Conference Call

TORONTO, March 26, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or “ Company ”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based produc...

AVCN:CC - ThreeD Capital Inc. Announces New YouTube Channel

TORONTO, March 25, 2024 (GLOBE NEWSWIRE) -- ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQX:IDKFF) a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is e...

AVCN:CC - Avicanna Hosts Symposium on Cannabinoid-based Medicine  

TORONTO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is ...
AVCN:CC - Avicanna Announces New Research Collaboration with a Multi-national European-based Pharmaceutical Company

TORONTO, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is ...

AVCN:CC - Avicanna Obtains Its First Indication-Specific Drug Registration with Trunerox(TM)

TORONTO, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is ...

AVCN:CC - Avicanna Announces Supply and Licensing Agreement with Multinational Pharmaceutical Company

Exclusive supply agreement for two of Avicanna’s proprietary topical products in the European region Right of first refusal agreement for the Avicanna’s SEDDs capsules in the European region TORONTO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avi...
Previous 10 Next 10